Anthem Biosciences IPO Subscription started on Monday, July 14, and will close on July 16, 2025, as scheduled. The price band is set at ā¹540 to ā¹570 per share with a face value of ā¹2.Ā
Anthem BiosciencesĀ IPO Subscription Status
Anthem Biosciences IPO subscribed over 0.77x on its First day till 05.00 PM on 14th July.
- Anthem Biosciences IPO subscription QIB investors portion is 0.39x times, while NII subscribers subscribed 1.64x times, and RII investors subscribed 0.62x times.
- The company has received bids for 3,22,28,066 shares against 4,17,50,321 shares on offer on the First day.
- Anthem Biosciences IPO subscribed over 0.77x on day 1.
About Anthem BiosciencesĀ IPOĀ
Anthem Biosciences Limited, founded in 2006, is one of the growing innovation-driven and technology-focused Contract Research, Development and Manufacturing Organizations (āCRDMOā) with end-to-end operations covering drug discovery, development, and manufacturing. Anthem Biosciences is one of the few companies in India with integrated capabilities in New Chemical Entities (NCE) and New Biological Entities (NBE) throughout drug discovery, development, and commercial manufacturing.
Anthem Biosciences is a one-stop service provider engaged in serving a wide range of customers, including emerging biotech companies and large pharmaceutical firms around the world. The company is involved in the manufacturing of specialized fermentation-based APIs, including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars. The company has supplied to over 150 customers, from small biotech to large pharmaceutical companies, as of March 31, 2024. Currently, the company has a team of 600 employees, including medicinal chemists, microbiologists, molecular biologists, biochemists, and chemical engineers.
Anthem BiosciencesĀ IPO Company Financial Report
The company reported revenue of ā¹1,930.29 crores in 2025 against ā¹1,483.07 crores in 2024. The company reported a profit of ā¹451.26 crores in 2025 against a profit of ā¹367.31 crores in 2024.
Anthem Biosciences IPO GMP:
Anthem Biosciences IPO GMP was ā¹100 as of Monday, July 14th, 2025. That indicates the IPO is trading at ā¹670 with a ā¹100 premium in the grey market against the issue price of ā¹570.
